TG News and Press, Tredegar Corporation

2026-03-11 08:33:14 ET More on Tredegar Tredegar Trades At A Deep Discount As The Market Tests A Recovery Tredegar: Besides Uncertainty, Expect Nothing More Financial information for Tredegar Read the full article on Seeking Alpha For further details ...

Tredegar Corporation (NYSE:TG, also the “Company” or “Tredegar”) today reported fourth quarter and full year financial results for the period ended December 31, 2025. Fourth quarter 2025 net income (loss) from continuing operations was $14.5 million ($0.42 per dilu...

Tredegar Corporation (NYSE:TG) plans to release financial results for the fourth quarter of 2025 on March 11, 2026. About Tredegar Tredegar Corporation is an industrial manufacturer with two primary businesses: custom aluminum extrusions for the North American building & constructio...

Bonnell Aluminum, a subsidiary of Tredegar Corporation (NYSE:TG), is pleased to announce the appointment of Tracy Bridges to the position of Vice President of Sales and Marketing, effective March 1, 2026. She will be replacing Eric Yost, who will be retiring from the Company after 28 years of ser...

2026-02-11 11:11:41 ET More on small caps 2026: The Year Of The Small Cap? The Small Cap Rotation - Thoughts And How To Play It What Happens When Small Caps Win The Race To The 10th Trading Day? Top small-cap energy stocks surging above 200-Day moving average...

Tredegar Corporation (NYSE:TG) today announced that it has appointed David Parks as an independent director to its Board of Directors. “David’s combination of extensive engineering experience, global commercial leadership, and strategic insight makes him an outstanding addition ...

2025-12-17 10:43:23 ET Tredegar Corporation ( TG ) is navigating a mixed market environment as the automotive industry undergoes a major transition away from EVs into traditional ICE and hybrid vehicle models, paired with a challenging building & construction environment. With a low...

2025-12-15 08:00:00 ET “Hold” Rating for Tredegar Corporation Read the full article on Seeking Alpha For further details see: Tredegar: Besides Uncertainty, Expect Nothing More

2025-12-04 10:29:50 ET Crispr Therapeutics AG ( CRSP ) was founded in 2013 and is based in Zug, Switzerland. It is the market leader in transformative therapies incorporating CRISPR/Cas9 technology, solidifying its position after receiving approval by the FDA (Dec 2023) & EMA (F...

2025-11-20 17:59:40 ET More on Tredegar Seeking Alpha’s Quant Rating on Tredegar Financial information for Tredegar Read the full article on Seeking Alpha For further details see: Tredegar announces CEO, CFO transitions